Products

What will AGI do for Bifonazole?

This classification denotes an antifungal agent with the molecular formula C22H18N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QYJ305Z91O, chemically known as 1-(p,alpha-diphenylbenzyl)imidazole but generally known as bifonazole, which bears US NIH Compound Identifier 2378. European Medicines Agency schedules Bifonazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05831MIG. The term BIFONAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). World Health Organization schedules bifonazole in its Anatomical Therapeutic Chemical (ATC) Classification. BIFONAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bifonazole under HS 29332990 and SITC 51573. As of Q4 2014, BIFONAZOLE remains the US FDA Preferred Term for this commodity. Bifonazole bears US NLM identifiers UMLS ID C0053570 and NCI Concept Code C87450. SMILES: N1(C(C2CCC(CC2)C2CCCCC2)C2CCCCC2)CCNC1.